Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C11H13N5O3 |
| Molecular Weight | 263.2526 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC2=C(N=CN2\C=C3\CC3(CO)CO)C(=O)N1
InChI
InChIKey=KMUNHOKTIVSFRA-KXFIGUGUSA-N
InChI=1S/C11H13N5O3/c12-10-14-8-7(9(19)15-10)13-5-16(8)2-6-1-11(6,3-17)4-18/h2,5,17-18H,1,3-4H2,(H3,12,14,15,19)/b6-2-
| Molecular Formula | C11H13N5O3 |
| Molecular Weight | 263.2526 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Synthesis and antiviral activities of methylenecyclopropane analogs with 6-alkoxy and 6-alkylthio substitutions that exhibit broad-spectrum antiviral activity against human herpesviruses. | 2013-08 |
|
| Cytomegalovirus UL97 mutations affecting cyclopropavir and ganciclovir susceptibility. | 2011-01 |
|
| Phosphonate analogues of cyclopropavir phosphates and their E-isomers. Synthesis and antiviral activity. | 2009-06-01 |
|
| (Z)- and (E)-2-(1,2-dihydroxyethyl)methylenecyclopropane analogues of 2'-deoxyadenosine and 2'-deoxyguanosine. Synthesis of all stereoisomers, absolute configuration, and antiviral activity. | 2009-05-28 |
|
| Preclinical evaluation of GS-9160, a novel inhibitor of human immunodeficiency virus type 1 integrase. | 2009-03 |
|
| Novel indazole non-nucleoside reverse transcriptase inhibitors using molecular hybridization based on crystallographic overlays. | 2009-02-26 |
|
| Fluorinated methylenecyclopropane analogues of nucleosides. Synthesis and antiviral activity of (Z)- and (E)-9-{[(2-fluoromethyl-2-hydroxymethyl)-cyclopropylidene]methyl}adenine and -guanine. | 2008-03-01 |
|
| In vitro activity and mechanism of action of methylenecyclopropane analogs of nucleosides against herpesvirus replication. | 2005-03 |
|
| Nucleotides and pronucleotides of 2,2-bis(hydroxymethyl)methylenecyclopropane analogues of purine nucleosides: synthesis and antiviral activity. | 2005-01-13 |
|
| Oral activity of a methylenecyclopropane analog, cyclopropavir, in animal models for cytomegalovirus infections. | 2004-12 |
|
| Synthesis and antiviral activity of (Z)- and (E)-2,2-[bis(hydroxymethyl)cyclopropylidene]methylpurines and -pyrimidines: second-generation methylenecyclopropane analogues of nucleosides. | 2004-01-29 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14736238
Filociclovir (cyclopropavir) is 10-fold more effective against human cytomegalovirus in vitro than ganciclovir (50% effective concentrations [EC50s]=0.46 and 4.1 uM, respectively) without any observed increase in cytotoxicity.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:09:53 GMT 2025
by
admin
on
Mon Mar 31 21:09:53 GMT 2025
|
| Record UNII |
EAO0TD9B13
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
319010
Created by
admin on Mon Mar 31 21:09:53 GMT 2025 , Edited by admin on Mon Mar 31 21:09:53 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
EAO0TD9B13
Created by
admin on Mon Mar 31 21:09:53 GMT 2025 , Edited by admin on Mon Mar 31 21:09:53 GMT 2025
|
PRIMARY | |||
|
632325-71-4
Created by
admin on Mon Mar 31 21:09:53 GMT 2025 , Edited by admin on Mon Mar 31 21:09:53 GMT 2025
|
PRIMARY | |||
|
DB12438
Created by
admin on Mon Mar 31 21:09:53 GMT 2025 , Edited by admin on Mon Mar 31 21:09:53 GMT 2025
|
PRIMARY | |||
|
9905
Created by
admin on Mon Mar 31 21:09:53 GMT 2025 , Edited by admin on Mon Mar 31 21:09:53 GMT 2025
|
PRIMARY | |||
|
C495219
Created by
admin on Mon Mar 31 21:09:53 GMT 2025 , Edited by admin on Mon Mar 31 21:09:53 GMT 2025
|
PRIMARY | |||
|
C169979
Created by
admin on Mon Mar 31 21:09:53 GMT 2025 , Edited by admin on Mon Mar 31 21:09:53 GMT 2025
|
PRIMARY | |||
|
300000034191
Created by
admin on Mon Mar 31 21:09:53 GMT 2025 , Edited by admin on Mon Mar 31 21:09:53 GMT 2025
|
PRIMARY | |||
|
Filociclovir
Created by
admin on Mon Mar 31 21:09:53 GMT 2025 , Edited by admin on Mon Mar 31 21:09:53 GMT 2025
|
PRIMARY | |||
|
135409256
Created by
admin on Mon Mar 31 21:09:53 GMT 2025 , Edited by admin on Mon Mar 31 21:09:53 GMT 2025
|
PRIMARY | |||
|
CHEMBL265948
Created by
admin on Mon Mar 31 21:09:53 GMT 2025 , Edited by admin on Mon Mar 31 21:09:53 GMT 2025
|
PRIMARY | |||
|
DTXSID10212612
Created by
admin on Mon Mar 31 21:09:53 GMT 2025 , Edited by admin on Mon Mar 31 21:09:53 GMT 2025
|
PRIMARY | |||
|
ZZ-46
Created by
admin on Mon Mar 31 21:09:53 GMT 2025 , Edited by admin on Mon Mar 31 21:09:53 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|